Compare · MDLN vs XAIR
MDLN vs XAIR
Side-by-side comparison of Medline Inc. (MDLN) and Beyond Air Inc. (XAIR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and XAIR operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 9825.2x XAIR ($4.8M).
- Over the past year, MDLN is down 12.5% and XAIR is down 90.0% - MDLN leads by 77.4 points.
- MDLN has been more active in the news (12 items in the past 4 weeks vs 10 for XAIR).
- MDLN has more recent analyst coverage (25 ratings vs 5 for XAIR).
- Company
- Medline Inc.
- Beyond Air Inc.
- Price
- $35.64+2.77%
- $4.59-11.05%
- Market cap
- $46.86B
- $4.8M
- 1M return
- -10.28%
- -10.09%
- 1Y return
- -12.54%
- -89.98%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 12
- 10
- Recent ratings
- 25
- 5
Beyond Air Inc.
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest XAIR
- Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
- SEC Form EFFECT filed by Beyond Air Inc.
- SEC Form 424B3 filed by Beyond Air Inc.
- Beyond Air Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-3 filed by Beyond Air Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Beyond Air Inc.
- SEC Form 10-Q filed by Beyond Air Inc.
- Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
- SEC Form 8-K filed by Beyond Air Inc.
- Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026